Alterity Therapeutics Limited (PRNAF)
OTCMKTS
· Delayed Price · Currency is USD
0.0139
0.00 (0.00%)
At close: May 12, 2025
Alterity Therapeutics Employees
Alterity Therapeutics had 10 employees as of June 30, 2024. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
$230,490
Profits / Employee
-$1,224,681
Market Cap
58.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 9 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Alterity Therapeutics News
- 4 days ago - Alterity Therapeutics Prominently Featured at the International MSA Congress - GlobeNewsWire
- 9 days ago - Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress - GlobeNewsWire
- 11 days ago - Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy - GlobeNewsWire
- 16 days ago - Appendix 4C – Q3 FY25 Quarterly Cash Flow Report - GlobeNewsWire
- 18 days ago - Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium - GlobeNewsWire
- 5 weeks ago - Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting - GlobeNewsWire
- 7 weeks ago - Alterity Therapeutics Completes Last Patient Visit in ATH434-202 Open-Label Phase 2 Trial in Multiple System Atrophy - GlobeNewsWire
- 3 months ago - Alterity Therapeutics raises A$40 million - Seeking Alpha